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Hypothalamic S1P/S1PR1 axis controls energy
homeostasis
Vagner R.R. Silva1, Thayana O. Micheletti2, Gustavo D. Pimentel2, Carlos K. Katashima2, Luciene Lenhare2,
Joseane Morari3, Maria Carolina S. Mendes2, Daniela S. Razolli3, Guilherme Z. Rocha2, Claudio T. de Souza4,
Dongryeol Ryu5, Patrı´cia O. Prada2, Lı´cio A. Velloso3, Jose´ B. C. Carvalheira2, Jose´ Rodrigo Pauli1,
Dennys E. Cintra1,2,3 & Eduardo R. Ropelle1,2
Sphingosine 1-phosphate receptor 1 (S1PR1) is a G-protein-coupled receptor for sphingosine-
1-phosphate (S1P) that has a role in many physiological and pathophysiological processes.
Here we show that the S1P/S1PR1 signalling pathway in hypothalamic neurons regulates
energy homeostasis in rodents. We demonstrate that S1PR1 protein is highly enriched in
hypothalamic POMC neurons of rats. Intracerebroventricular injections of the bioactive lipid,
S1P, reduce food consumption and increase rat energy expenditure through persistent
activation of STAT3 and the melanocortin system. Similarly, the selective disruption of
hypothalamic S1PR1 increases food intake and reduces the respiratory exchange ratio. We
further show that STAT3 controls S1PR1 expression in neurons via a positive feedback
mechanism. Interestingly, several models of obesity and cancer anorexia display an imbalance
of hypothalamic S1P/S1PR1/STAT3 axis, whereas pharmacological intervention ameliorates
these phenotypes. Taken together, our data demonstrate that the neuronal S1P/S1PR1/STAT3
signalling axis plays a critical role in the control of energy homeostasis in rats.
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T
he hypothalamus plays an important role in the regulation
of energy homeostasis controlling feeding behaviour and
energy metabolism in mammals1. Body weight and
appetite control are complex and incompletely characterized. It
has been postulated that central mechanisms disturbance can lead
to hyperfagia or anorexia. In this context, Janus kinase/signal
transducer and activator of transcription (Jak/STAT) signalling
plays a fine tune in the control of anorexigenic and thermogenic
signal on hormonal2,3 or inflammatory stimulus4–6. The
disturbance in the hypothalamic Jak2/STAT3 signalling results
in anomalous neurotransmitters production, generating abnormal
anorexigenic and thermogenic response, and favouring body
mass gain or severe weight loss5,7–10. Thus, alternative strategies
to control Jak/STAT cascade activation in the hypothalamus
could be considered as potential therapeutic targets to maintain
the energy homeostasis during abnormal feeding behaviour, such
as hyperphagia and anorexia.
Recently, a class of sphingosine 1-phosphate receptors (S1PRs)
has been implicated in the control of Jak2/STAT3 signalling11–14.
S1PRs family is comprises five (1–5) specific G-protein-coupled
receptors that activate diverse downstream signalling pathways in
response to the common sphingosine-1-phosphate (S1P)15. The
lysophospholipid, S1P, is a circulating bioactive lipid metabolite
formed by phosphorylation of sphingosine, in a reaction catalysed
by sphingosine kinase, SPHK1 and 2 (ref. 16). S1P/S1PRs axis
plays a important role in the control of cardioprotection11,
intestinal inflammation12, satellite cell activation17 and tumour
cells progression13 through the persistent STAT3 activation.
However, the role of hypothalamic S1P/S1PR1/STAT3 axis in the
control of the energy homeostasis was not reported.
Here we combined the physiological, pharmacological and
genetic approaches, and transcriptome analysis to investigate the
participation of hypothalamic S1P/S1PR1 axis in the control of
anorexigenic signals, food consumption and energy expenditure
in rodents. In addition, we examined the role of neuronal S1P/
S1PR1/STAT3 signalling in distinct conditions of abnormal
feeding behaviour, including obesity and cancer-induced
anorexia.
Results
Characterization of hypothalamic S1PR1. We sought to deter-
mine the role of S1PR1 in hypothalamic neurons in the control of
the energy homeostasis. First, we evaluate the distribution of
S1PR1 in different tissues of normal rats and observed that the
S1PR1 protein was highly enriched in the hypothalamus, when
compared with peripheral tissues, such as the heart, liver, skeletal
muscle and adipose tissues (Fig. 1a). Thereafter, we examine the
S1PR1 distribution pattern in the hypothalamus using the micro
dissection of hypothalamic nuclei. This technique revealed that
S1PR1 is expressed predominantly in the arcuate and ven-
tromedial/dorsomedial nuclei in the hypothalamus and low pro-
tein levels were found in paraventricular (PVN) nucleus and in
lateral hypothalamus (Fig. 1b). These data were confirmed by
immunostaining assay (Fig. 1c, left panel). We also employed the
double staining and observed that S1PR1 is stained predominantly
in anorexigenic (pro-opiomelanocortin (POMC)), but not in
orexigenic (neuropeptide Y (NPY)) neurons in the arcuate nucleus
(Fig. 1c). We noted that S1PR1 is stained in the neurons but is
barely stained in non-neuronal cells (such as astrocytes) in the
arcuate nucleus (Supplementary Fig. 1A). We also monitored the
S1PR1 expression in other regions of the brain, including fore-
brain, midbrain and hindbrain, and high levels of S1PR1 were also
found in midbrain of rats (Supplementary Fig. 1B).
Once S1PR1 is localized in hypothalamic nuclei and in neurons
specialized in the control of energy homeostasis, we sought to
determine whether the physiological nutritional status modulates
the hypothalamic S1PR1 expression. We observed that 12 h of
fasting was sufficient to reduce S1PR1 protein level in the
hypothalamus of control rats by about 60%, whereas the refeeding
period (6 h) restored the protein levels of this receptor (Fig. 1d).
In addition, hypothalamic STAT3 tyrosine phosphorylation
accompanied the pattern of S1PR1 protein levels in the fasting/
refeeding experiment (Fig. 1d, middle panel). After these results,
we hypothesized that neuronal S1PR1 could be involved in the
control of the energy homeostasis through the positive cross-talk
mechanism, involving Jak/STAT3 cascade in neurons, as
observed in other cell types11–14,17.
Next, we examined the relationship between the S1PR1 and
Jak/STAT signalling in the hypothalamus. We detected that most
neurons expressing S1PR1 in the arcuate nucleus were shown to
possess STAT3 in control rats, suggesting a possible interaction
between these molecules (Fig. 1c, lower panels). To determine
whether S1PR1 activates hypothalamic STAT3, we next carried
out a bilateral cannulation to access the ventromedial hypotha-
lamus (VMH; Supplementary Fig. 1C), and then used the
endogenous S1PR1 activator, S1P (50 ng), into one side of the
VMH and vehicle into the other side of the VMH in the same rat
(Fig. 1e), as previously described18. Interestingly, S1P, but not
vehicle, induced tyrosine phosphorylation of STAT3 in the
hypothalamus of control rats (Fig. 1f). Collectively, these data
indicate that the hypothalamic S1PR1 is localized in the
mediobasal of the hypothalamus in neurons specialized in the
control of energy homeostasis, and that S1PR1 activation
increases the STAT3 activity in the hypothalamus of rats.
Central S1P/S1PR1 controls energy homeostasis. Thereafter, we
evaluate the effects of S1PR1 activator, S1P, in the control of food
intake and energy expenditure in rodents. We performed an acute
injection of S1P in the third ventricle of rats in different doses
(2 and 50 ng) and monitored the food consumption during 4 and
12 h. S1P reduced the food intake in a dose-dependent manner
(Fig. 2a). To evaluate the possibility that the anorectic effect of
S1P was caused by an aversive effect, we measured taste reactivity
after acute intracerebroventricular (ICV) S1P injection. The total
numbers of hedonic, neutral and aversive reactions remained
unchanged (Supplementary Fig. 2A). We also performed chronic
(3 days) of ICV S1P (50 ng) injections and we observed a con-
sistent anorexigenic effect during 3 consecutive days in control
rats; on the other hand, after these injections, these animals
rapidly returned to the baseline of food intake, in a similar
manner as observed in the pair-feeding group (Supplementary
Fig. 2B). These data demonstrated that S1P ICV injection does
not evoke a taste aversion or toxic effect.
Western blotting analysis confirmed that S1P increased Jak2
and STAT3 tyrosine phosphorylation in the hypothalamus in a
dose-dependent manner (Fig. 2b). To investigate whether S1PR1
activates directly the leptin signal transduction, we carried
out immunoprecipitation assay to evaluate the S1PR1/Jak2
association. Our experiments revealed that acute ICV injection
of S1P promoted the S1PR1/Jak2 association in the hypothalamic
tissue in a dose-dependent manner (Fig. 2c). However, acute
microinjection of S1P did not change the insulin receptor
substrate 1 (IRS1) and Akt phosphorylation in the hypothalamus
(Supplementary Fig. 2C).
It has been proposed that S1P mediates its biological effects
inducing S1PR1 internalization and subsequent degradation15,19.
To address the efficacy of S1P injection on S1PR1 activation, we
examine the subcellular expression of S1PR1 after S1P (50 ng)
ICV injection. We observed the downregulation of S1PR1 in the
membrane of the cells between 15 and 45min after S1P stimulus;
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5859
2 NATURE COMMUNICATIONS | 5:4859 | DOI: 10.1038/ncomms5859 | www.nature.com/naturecommunications
& 2014 Macmillan Publishers Limited. All rights reserved.
this phenomenon was accompanied by transitory cytoplasmic
S1PR1 accumulation, suggesting that S1P induced activation and
internalization of S1PR1 in hypothalamic cells (Fig. 2d).
We also monitored the energy expenditure and body
temperature after acute S1P (50 ng) injection. The ICV S1P
injection increased the energy expenditure in rats, increasing the
O2 consumption and CO2 production, in both, light and dark
periods (Fig. 2e), without any change in the physical activity
pattern (Supplementary Fig. 2D). ICV injection of S1P also
promoted the elevation of body temperature when compared with
vehicle (Fig. 2f). These data demonstrated that hypothalamic
S1PR1 stimulation induced a potent anorexigenic and thermo-
genic action.
Although S1P is considered the main endogenous S1PR1
activator, this molecule is able to activate other S1PRs20. Thus, we
performed an acute microinjection of specific S1PR1 activator
(SEW2871) into the third ventricle of rats. We observed that
SEW2871 (50 nM) reproduced the effects of S1P, reducing the
food intake (Fig. 2g) and activating the leptin signalling (Fig. 2h).
Consistent with the role of the hypothalamic S1PR1 activation in
the control of food consumption and on STAT3 activation, we
observed that acute SEW2871 injection into the third ventricle of
rats modulates the expression of neuropeptides involved in the
food intake and energy expenditure control. SEW2871 increased
POMC messenger RNA without changing NPY mRNA levels,
when compared with vehicle injection (Fig. 2i).
Next, we evaluate the impact of intraperitoneal S1P injection
(100 ng) on food intake and on energy expenditure in mice.
Interestingly, acute intraperitoneal injection of S1P reduced the
food consumption and promoted a discrete but significant
increase in energy expenditure (Supplementary Fig. 2E,F). No
statistical difference in body temperature was observed in
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Figure 1 | Characterization of S1PR1 in the hypothalamus of rats. Western blottings show (a) S1PR1 protein levels in different tissues of control rats
(n¼6). (b) S1PR1 protein levels in the arcuate (Arc), dorsomedial/vetromedial (DMH/VMH), PVN nucleus and in the lateral hypothalamus (LH) of control
rats (n¼ 6). Bars represent the mean±s.e.m. (c) Single and double immunostaining was performed to evaluate the co-localization of S1PR1 (green) with
POMC, NPY and STAT3 (red) in the arcuate nuclei of rats, with  50 magnification (left panel) or  200 magnification (scale bar, 20mm). (d) Western
blotting shows the S1PR1 protein levels and STAT3 tyrosine phosphorylation in hypothalamic samples of rats at 12 h of fasting and after 6 h of refeeding
(n¼ 5). (e) A schematic representation showing the localization of S1P injection. S1P was injected into the VMH of rats (coordinates 2.3/3.3mm posterior
to the bregma, ±0.6mm lateral to midline and 10.2mm below the surface of the skull). (f) Single immunostaining was performed to evaluate STAT3
tyrosine phosphorylation (green) in the hypothalamus of rats 30min after vehicle (left) or S1P 50 ng (right) injections in the same rat, with  100
magnification (scale bar, 20mm).
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C57BL6/J mice after acute intraperitoneal injection of S1P (peak
of temperature; Veh. 37.3±0.5 C versus S1P 37.5±0.8 C).
S1PR1 requires the leptin signalling and melanocortin system.
It has been demonstrated that Jak2/STAT3 signalling activators,
including interleukin-6, promotes a transient STAT3 activation,
while S1PR1 induces a persistent STAT3 phosphorylation13.
Based on this information, we suspected that S1P could induce a
potent anorexigenic effect through the persistent STAT3
activation. To address this question, we performed a time-
course study to examine STAT3 phosphorylation on acute leptin
or S1P ICV injections. The western blotting analysis revealed
that ICV infusion of leptin promoted a transient effect on
STAT3 phosphorylation. Leptin increased the tyrosine
phosphorylation of STAT3 after 15 and 30min, returning at
the basal levels after 60min (Fig. 3a,b). Notably, the ICV
infusion of S1P promoted potent and persistent phosphorylation
of this molecule, increasing STAT3 phosphorylation after 5min
and peaking at 120min later (Fig. 3a,b). We also monitored the
food consumption after acute leptin or S1P ICV injection in
control rats and we observed that S1P promoted a potent and
persistent anorexigenic effect when compared with leptin
(Fig. 3c).
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Figure 2 | Neuronal S1PR1 activation induces anorexigenic and thermogenic response. (a) Determination of food consumption after ICV injection of S1P
(2 or 50 ng) in control rats (n¼ 8). (b) Western blottings show S1P-induced Jak2tyr1007/1008 and STAT3tyr705 phosphorylation in hypothalamic samples of
Wistar rats 30min after S1P injections (n¼ 6). (c) Immunoprecipitation assay was performed to evaluate S1PR1/Jak2 association 30min after S1P
injections (n¼6). (d) Subcellular fractionation was performed to evaluate S1PR1 expression in membrane and cytoplasm of samples obtained from control
rats injected with S1P (50ng). (e) Oxygen consumption/carbon dioxide production after single injection of S1P into the third ventricle of control rats.
(f) Evaluation of the body temperature after acute ICV injection of S1P (50ng) in control rats (n¼ 5). (g) Determination of food consumption after ICV
injection of SEW2871 (50 nM) in control rats (n¼6). (h) Western blotting shows SEW-induced STAT3tyr705 phosphorylation in hypothalamic samples of
Wistar rats 30min after SEW injection (n¼4). (i) POMC and NPY mRNA were examined using real-time PCR assay 9 h after IICV SEW2871 (50nM)
injection (n¼8). Data were expressed by using mean±s.e.m.*Po0.05 versus vehicle and #Po0.05 versus S1P 2 ng. One-way analysis of variance was
used for statistical analysis in the a–c and unpaired t-test was used in e–i.
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To confirm whether S1PR1 anorexigenic action depends on the
Jak2 and STAT3 signalling, we used the pretreatment with
the inhibitor of STAT3, JSI124, before the S1P injection. To test
the efficacy of JSI124 in the hypothalamus, we performed an acute
injection using 50 mM into the third ventricle of control animals.
Western blot analysis showed that JSI124 reduced STAT3
tyrosine phosphorylation, when compared with vehicle injection
(Fig. 3d). Interestingly, the JSI124 pretreatment, 30min before
S1P ICV injection, was sufficient to block, at least in part, the
anorexigenic action of S1P injection (Fig. 3e) and reduced the
S1P-induced STAT3 phosphorylation in the hypothalamus
(Fig. 3f). Acutely, ICV JSI124 alone did not change the food
consumption (Veh. 13.8±1.2 g versus JSI124 12.6±2.3 g).
Accumulating number of studies have demonstrated that
hypothalamic STAT3 tyrosine 705 phosphorylation precedes
STAT3 DNA binding, promoting transcriptional activation of the
POMC promoter, induced by anorexigenic factors, including
leptin2,21–23 or cytokines24–26. Thus, we evaluated the STAT3
nuclear translocation after S1P ICV injection in control rats. The
time-course study revealed that S1P (50 ng) induced a rapid and
persistent STAT3 nuclear accumulation (Fig. 3g).
To confirm our experimental findings, we performed a
bioinformatics analysis using the BXD murine reference panel
for multiscalar integration of traits previously published27. The
transcriptome data from the hypothalamus revealed that S1pr1
mRNA levels strongly correlated with the expression of Pomc in
the hypothalamus of BXD inbred strains (n¼ 33). Furthermore,
we also found a strong positive correlation among hypothalamic
S1pr1 mRNA, and Mc3r and Mc4r, without correlation between
S1pr1, and Agrp and Npy levels. (Fig. 3h,i). Not surprisingly,
hypothalamic S1pr1 expression has a strong negative correlation
with food intake and body weight but not with locomotor activity
and lean body mass (Fig. 3j,k). These data are in accordance with
our experimental data and suggest that the anorexigenic S1PR1
signal could be projected to the secondary neurons, involving the
melanocortin system.
To confirm the role of S1PR1 on melanocortin system, we
performed the ICV injection of a potent melanocortin MC3 and
MC4 receptor antagonist, SHU9119 (1.0mM), in control rats.
This experiment revealed that SHU9119 pretreatment partially
prevented the anorexigenic effects of S1P ICV injection (Fig. 3l).
These data indicate that an anorexigenic effect of hypothalamic
S1P/S1PR1 axis requires, at least in part, the STAT3 activation
and the melanocortin system.
Hypothalamic S1PR1 disruption affects the energy home-
ostasis. Next, we examined the effects of specific hypothalamic
S1PR1 knockdown using the small interfering RNAs (siRNAs)
in vivo, as previously described28,29. The siRNA against S1PR1
was complexed with JetSI lipids and administered bilaterally into
the mediobasal hypothalamus (MBH) of intact mice. To access
the MBH of mice, we performed an acute bilateral injection, as
represented in the Fig. 4a. The time-course study revealed that
S1PR1 siRNA injection promoted a transient reduction S1PR1
protein levels in the VMH/ dorsomedial hypothalamus (DMH),
whereas the efficacy of the siRNA was about 60% in the first 24 h
(Fig. 4b). The siRNA reduced S1PR1 protein level in the arcuate
nucleus, without change S1PR1 protein level in other brain areas,
including, forebrain, midbrain and hindbrain (Fig. 4c).
Interestingly, the hyperphagic response was observed only
during the transient disruption of S1PR1 MBH of mice
(Fig. 4d). The hyperphagia persisted until 36 h after S1PR1
siRNA injection (Fig. 4e). Consistent with the downregulation of
hypothalamic S1PR1, low levels of STAT3 phosphorylation were
observed in mice under fed condition (Fig. 4f). No difference in
the total body weight was observed 48 h after S1PR1 siRNA
injection (Scramble 26.3±0.6 g versus 26.7±0.7 g).
We also measured the energy expenditure during 24 h after
S1PR1 siRNA injection in MBH of mice. These mice displayed
reduction in the energy expenditure, as demonstrated by the low
levels of VCO2 production and respiratory exchange ratio
(Fig. 4g). Taken together, these data demonstrated that transient
S1PR1 disruption in discrete hypothalamic nucleus alters the
energy balance in mice.
STAT3 controls the hypothalamic S1PR1 protein levels. The
transcriptome data from hypothalamus of BXD mice demon-
strated a strong positive correlation between Stat3 and S1pr1
levels (Fig. 3h,i). In accordance with this data, it has been
demonstrated that STAT3 directly binds to the S1pr1 promoter,
increasing the S1PR1 mRNA levels in tumour cells13. To address
whether STAT3 activation modulates S1PR1 protein levels in
neurons, we employed the cell culture system using neuronal
GT1-7 cells treated with leptin. We carried out a time-course
study and observed that leptin (40 mmol l 1) increased S1PR1
protein levels in GT1-7 cells in a time-dependent manner
(Fig. 5a). Next, we used STAT3 siRNA in GT1-7 cells (Fig. 5b) to
evaluate the requirement of STAT3 on leptin-induced S1PR1
expression. We observed that leptin failed to increase S1PR1
protein levels in GT1-7 cells transfected with STAT3 siRNA
(Fig. 5c).
We then evaluated the effects of leptin in the control of S1PR1
protein levels in vivo. Similar to GT1-7 cells, acute ICV infusion
of leptin increased S1PR1 protein levels in the hypothalamus of
control rats, as demonstrated in the time-course study (Fig. 5d).
On the other hand, ICV JSI-124 pretreatment blocked the effect
Figure 3 | S1PR1 requires STAT3 activation to induce anorexia. (a) Western blottings show leptin-induced STAT3 phosphorylation (upper panel) and
S1P-induced STAT3 phosphorylation (lower panel) after ICV stimulation (n¼4 in each point). (b) Representation of STAT3 phosphorylation pattern after
leptin or S1P ICV injections. (c) Determination of food consumption after ICV injection of saline (2ml), leptin (106M) or S1P (50ng) in control rats
(n¼ 10). (d) Western blotting shows the effects of JSI124 (50mM) on STAT3 phosphorylation in the hypothalamus (n¼4). (e) Food intake evaluation after
vehicle (2ml), S1P (50 ng) and JSI124 (50mM) plus S1P injection. (f) Western blotting shows the effects of JSI124 (50mM) on S1P-induced STAT3
phosphorylation in the hypothalamus (n¼4). (g) Nuclear STAT3 translocation after ICV injection of S1P (50 ng) (n¼ 3, in each point). (h) Correlation
matrices (left lower triangle) and pie graphs (right upper triangle) showing correlations among S1pr1, Stat3, Pomc, Mc3r, Mc4r, Npy and Agrp in the
hypothalamus of the BXD inbred family (n¼ 33, GSE36674). The depth of the shading at the correlation matrices indicates the magnitude of the
correlation. Positive and negative correlations are represented in blue and red, respectively. The pie graphs are filled in proportion to the Pearson’s
coefficient values, clockwise for positive correlations (in blue) and anti-clockwise for negative correlations (in red). (i) Interaction network showing
correlations of indicated genes. Positive Pearson’s correlation coefficients are represented by blue solid (r¼0.5–1.0) and dashed line (r¼0.4–0.5).
(j) Correlation plots between hypothalamic S1pr1 and each indicated phenotype (n¼ 10 to 29). Pearson’s coefficient values were used to analyse
correlations, and Pearson’s r and P-values are indicated. (k) Interaction network showing correlations between hypothalamic S1pr1 and each indicated
phenotype. Positive Pearson’s correlation coefficients are represented by blue and red lines (r¼0.5–1.0). (l) Food consumption evaluation was performed
after vehicle (2ml), S1P (50 ng) and SHU9119 (1mmol) plus S1P injection (n¼ 5). Data were expressed by using mean±s.e.m. *Po0.05 versus vehicle,
yPo0.05 versus leptin group and #Po0.05 versus vehicle plus S1P. One-way analysis of variance and Bonferroni post test were performed in e,f and l.
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of leptin on hypothalamic S1PR1 protein levels in rats (Fig. 5e).
To confirm the role of leptin in the control of hypothalamic
S1PR1 expression in vivo, we examine the S1PR1 protein content
in the hypothalamus of mice lacking leptin (ob/ob). Interestingly,
ob/ob mice display dramatic reduction on S1PR1 expression
(88%) in the hypothalamus, when compared with wild-type mice
(Fig. 5f). Similar results were found in mice with deficiency in the
leptin signalling, db/db mice (Fig. 5g). These data demonstrate
that STAT3 activation plays a reciprocal role in the regulation of
hypothalamic S1PR1 protein levels.
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Downregulation of hypothalamic S1PR1 in obese rodents.
Based on our results, we hypothesized that S1PR1 expression
could be affected in the hypothalamus under obesity condition, as
a reflex of the leptin resistance. Thus, we then examined the
effects of high-fat diet (HFD) on hypothalamic leptin resistance
and S1PR1 protein levels. Initially, we observed that HFD reduced
the hypothalamic S1PR1 protein levels by about 35%, 50% and
75%, in Wistar rats, C57BL6/J and Swiss mice, respectively
(Fig. 6a–c). Consistent with the S1PR1 protein levels, real-time
PCR analysis revealed low S1PR1 mRNA levels in the hypotha-
lamus of Wistar rats after HFD treatment (Fig. 6d).
We next evaluate the effects of leptin to induce S1PR1 protein
levels in the hypothalamus of lean and obese rats. Initially, we
observed that ICV infusion of leptin promoted a strong STAT3
tyrosine phosphorylation in control but not in obese animals, as
expected (Supplementary Fig. 3A). Thereafter, we note that in
contrast to lean animal, acute ICV injection of leptin failed to
increase S1PR1 mRNA (Supplementary Fig. 3B) and protein levels
(Supplementary Fig. 3C) in the hypothalamus of obese rats. These
data demonstrate that central leptin resistance is associated with
the downregulation of S1PR1 in the hypothalamus of obese rats.
We then monitored the S1P serum levels in obese animals,
using ELISA kit specific to detect S1P in the serum of mouse. We
observed that obese mice (C57BL6/J) displayed an augment in the
serum levels of S1P when compared with control group (Fig. 6e).
The high levels of S1P suggest that it could be a compensatory
mechanism to subvert the downregulation of S1PR1 and defective
STAT3 activity in the hypothalamus of obese mice. Thus, we
investigated whether the forced activation of S1PR1 in the
hypothalamus of obese animals through S1P ICV injection is
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capable of overcoming leptin resistance, activate STAT3 and
recapitulate the anorexigenic signals in obese rats. We performed
an acute injection of S1P (50 ng) into the third ventricle of obese
rats to evaluate the energy intake and STAT3 phosphorylation. As
observed in control animals, S1P was sufficient to reduce the food
intake in obese rats (Fig. 6f); similar results were found when we
used a specific S1PR1 activator, SEW2871 (Fig. 6f). Western
blotting analysis demonstrated that acute S1P or SEW2871 ICV
injections were able to increase STAT3 tyrosine phosphorylation
in the hypothalamus of obese rats (Fig. 6g). Furthermore, acute
S1P injection increased POMC mRNA levels in the hypothalamus
of obese rats (Fig. 6h). However, we did not observe difference in
the energy expenditure after acute S1P ICV injection in obese rats
when compared with vehicle group (Fig. 6i) and no difference was
found in the physical activity pattern (Fig. 6j). Apparently, the
anorexigenic and thermogenic effects of S1P were more robust in
lean than obese animals.
Thereafter, to evaluate the impact of chronic S1P administra-
tion in obese rats, we performed a chronic micro infusion of S1P
(0.25ml h 1 with 50 ng per day) in the hypothalamus using
osmotic mini-pump. We observed that chronic S1P delivery in
the hypothalamus promoted reduction on daily food intake
(Fig. 6k), body weight (Fig. 6l) and epididymal fat-pad weight in
obese rats (Fig. 6m), when compared with vehicle infusion. These
data demonstrated that chronic S1P administration into the third
ventricle of animals reduced the food consumption and body
weight in obese rats.
Aberrant S1PR1 activation during cancer-induced anorexia.
Several studies have demonstrated that S1P levels are involved in
persistent STAT3 activation in cancer cells and in tumour
microenvironment, and for malignant progression13,14. In
addition, high levels of circulating S1P levels were found in
tumour-bearing animals14,30. In line with these evidences, we
sought to investigate whether S1P contributes to anorexia in
tumour-bearing rodents. We examined S1PR1 protein levels in
the hypothalamus of rats injected with Walker-256 tumour cells
and in mice injected with Lewis lung carcinoma (LLC) during
tumour-induced anorexia. The LLC cells induced severe anorexia
and weight loss in mice (Fig. 7a–c). Interestingly, 4 days after
onset of anorexia, high levels of S1PR1 protein levels and
hyperphosphorylation of STAT3 were found in hypothalamic
tissue of anorectic mice (Fig. 7d). Despite the high levels of
hypothalamic S1PR1 in anorectic mice, we sought to determine
the subcellular localization of this receptor. We detected the
abundance of S1PR1 in the membrane and cytoplasm in samples
obtained from hypothalamus anorectic mice, when compared
with control animals (Supplementary Fig. 3D,E).
High S1P serum levels were found in mice during cancer-
induced anorexia (Fig. 7e). Furthermore, we detected the presence
of high levels of S1P in cerebrospinal fluid (CSF) in tumour-
bearing mice (Fig. 7f), suggesting that S1P could be involved in
the aberrant anorexigenic signals in these animals. We also
investigate S1PR1 protein level and STAT3 in different models of
cancer-induced anorexia. For instance, Walker-256 tumour cells
also induced anorexia and weight loss in rats (Fig. 7g, h), and high
protein levels of S1PR1 and hyperphosphorylation of STAT3
were found in the hypothalamus of anorectic rats with Walker-
256 tumour (Fig. 7i).
To determine whether the presence of S1P in CSF of tumour-
bearing animals induces anorexia, we collected CSF from control
and anorectic Wistar rats and injected the CSF (2 ml) into the
third ventricle of control rats. The acute ICV injection of CSF
from control animals did not change the food consumption
(Fig. 7j); conversely, ICV injection of CSF from anorectic animals
promoted a strong anorexigenic effect in control animals (Fig. 7j).
Interestingly, the anorexigenic effect of CSF from anorectic rats
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was blunted in animals that received ICV S1PR1 inhibitor
(FTY720) pretreatment 60min before the CSF injection (Fig. 7j).
To confirm the role of hypothalamic S1PR1 on cancer-induced
anorexia, we performed ICV injection of FTY720, a functional
antagonist of S1PR1, in Wistar rats during cancer-induced
anorexia. FTY720 is an immunosuppressant compound known
to modulate the immune system by acting as a functional
antagonist of S1PR1 and inducing its internalization and
degradation31,32. After the onset of anorexia, we injected
FTY720 (50 mM) daily. Our results revealed that FTY720
increased the daily food consumption (Fig. 7k) and cumulative
energy intake 4 days after the onset of anorexia (Fig. 7l), when
compared with vehicle-treated animals. Moreover, FTY720
ICV treatment reduced hypothalamic STAT3 tyrosine
phosphorylation in tumour-bearing animals (Fig. 7m). This
treatment also attenuated cancer-induced weight loss in tumour-
bearing rats (Fig. 7n). The ICV FTY720 treatment did not change
the tumour growth (TumourþVeh 35.3±2.8 g versus
Tumourþ FTY720 35.9±3.6 g).
Finally, we investigated whether the hypothalamic S1PR1
inhibition increases survival in tumour-bearing animals. After the
onset of the anorexia, tumour-bearing animals received a daily
ICV injection of vehicle or FTY720 (50 mM). As shown in the
Kaplan–Maier graphs, a daily central infusion of FTY720
statistically prolonged the survival in tumour-bearing animals,
whereas the median survival of tumour-bearing rats that received
vehicle was 6 days and chronic administration of FTY720
increased the median survival to 10 days (Fig. 7o). These data
suggests that S1P produced during the tumour development
triggers hypothalamic anorexigenic signals through the S1PR1/
STAT3 axis contributing to cancer-induced anorexia.
Discussion
S1PRs family is composed by five different receptors (1–5) that
activate diverse downstream signalling pathways in response to the
common S1P15. S1PR1 is unique in that it couples exclusively to
the Gi protein. This receptor is widely expressed, controlling the
cellular process in heart, skeletal muscle, colon14 and other tissues.
Although S1P receptors have been identified in the central nervous
system33,34, the presence and function of S1PR1 specifically in the
hypothalamus was not reported. Surprisingly, our study revealed
that hypothalamic nuclei are highly enriched with S1PR1 protein
levels, when compared with peripheral tissues. We identify that
S1PR1 is localized in POMC neurons; conversely, low expression
of S1PR1 was found in NPY neurons. We also observed that the
nutritional availability modulates the hypothalamic S1PR1
expression, whereas under fasting condition hypothalamic S1PR1
protein levels was reduced and refeeding was sufficient to increase
S1PR1 in the hypothalamus and this phenomenon was
accompanied by STAT3 activity, suggesting the participation of
this receptor on the control of the energy homeostasis.
The relationship between lysophospholipids and Jak/STAT3
signalling was initially observed in endothelial progenitor cells, once
S1P increased Jak2 phosphorylation through the activation of lipid
receptor S1PR3 (ref. 35); similar results were found in ventricular
cardiomyocytes, in this case, S1P increased STAT3 phosphorylation
through S1PR2 (ref. 11). Although we did not evaluate the
presence/function of the others subunits of S1PRs in the
hypothalamus, our data revealed that specific S1PR1 activator
(SEW2871) promoted consistent STAT3 activation and induced
anorexigenic and thermogenic response. However, S1P ICV
injection did not change IRS1 tyrosine and Akt serine
phosphorylation, suggesting that the effects of S1P/S1PR1 on food
intake occurred through the leptin but not insulin signalling. Our
data are in accordance with Lee et al.13 that showed that S1PR1
interacts with Jak2, leading to persistent STAT3 activation in
human tumour cells, whereas pharmacological Jak2 inhibitor
abrogated S1PR1-mediated STAT3 tyrosine phosphorylation in
MB49 tumour cells. We also demonstrated that neuronal S1PR1
induces the anorexigenic signals through the melanocortin system.
Importantly, our experimental findings were confirmed by the
transcriptome analysis, using the BXD database that displayed a
strong correlation among S1PR1 and anorexigenic and thermogenic
pathways. This bioinformatic study was able to detect a negative
correlation between the hypothalamic S1PR1 levels and the food
consumption and body weight in several strains of BXD mice.
Using in vivo and in vitro models we observed that leptin
increased S1PR1 protein levels in GT1-7 neuronal cells and in the
hypothalamus of rats. Importantly, we demonstrated that STAT3
inhibition blunted leptin-induced S1PR1 protein levels in both
models. These data could be explained once STAT3 directly binds
to and activates the S1pr1 promoter13. In addition, our results
revealed that leptin deficiency or leptin receptor deficiency lead
a strong reduction in S1PR1 hypothalamic levels, as observed in
ob/ob and db/db mice. Furthermore, HFD treatment induced
central leptin resistance and this phenomenon was accompanied
by low hypothalamic S1PR1 protein levels, showing the reciprocal
requirement among S1PR1 and STAT3 in hypothalamic neurons.
In the present study, the role of S1PR in MBH in the control of
the energy balance was investigated using the acute S1PR1 siRNA
injection in vivo. This methodology induced the transient S1PR1
downregulation in MBH of mice, promoting consistent
hyperphagia and abnormal thermogenic response. Although our
data demonstrated that downregulation of S1PR1 protein levels in
MBH affect the energy balance, this methodological approach
failed to demonstrate the significant difference in the body weight
gain of mice. Thus, the role of long-term S1PR1 downregulation
in the MBH in the control of the body weight remains unclear
and deserves further investigations.
Circulating molecules able to activate Jak2/STAT3 in hypotha-
lamic neurons through the cross-talk mechanisms generally affects
food intake and energy expenditure in mammals4–6,36. It has been
proposed that alternative activation of Jak2/STAT3 in the
hypothalamus through the glycoprotein 130 receptor (gp130R)
ligands, for instance, may play as potential therapeutic targets in
obesity37. Our study provide substantial evidences that a
circulating bioactive lipid metabolite, S1P, could be considered
the alternative molecule capable to activate Jak2/STAT3 signalling
pathway and recapitulate the anorexigenic signals in the
hypothalamus. We demonstrated that even with low expression
of hypothalamic S1PR1 observed in obese rats, ICV injection of
S1P or SEW2871 was sufficient to activate STAT3 and induce
anorexigenic effects in obese animals. On the other hand, we detect
augment of S1P serum levels in obese mice, when compared with
the lean group. These data are in accordance with previous study
that demonstrated that plasma levels of S1P were increased in ob/
obmice38. The augment in S1P levels in obese mice may occur as a
compensatory mechanism despite the low hypothalamic
S1PR1levels. However, the increased S1P levels observed in obese
animals is not enough to activate the S1PR1/STAT3 signalling in
the hypothalamus. The downregulation of S1PR1 protein level in
obese rodents seems to be associated with the impairment of
central S1P anorexigenic and thermogenic action in obese animals,
when compared with lean ones. In addition, the molecular
mechanisms of leptin resistance, such as, the protein tyrosine
phosphatase 1B39–41 and IKKb42–44 activation may contribute to
the impairment of S1PR1/Jak2 association and STAT3 activation
in response to S1P; however, this issue deserves further
investigations. Using the osmotic mini-pump to delivery S1P
specifically in the hypothalamus of obese rats resulted in a
significant reduction in food intake and body weight.
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The S1P synthesis occurs by phosphorylation of sphingosine,
in a reaction catalysed by sphingosine kinases, SPHK1 and
SPHK2 (ref. 15). Although, high levels of S1P were found in obese
and in tumour-bearing mice, the S1P sources are distinct in each
situation. An elegant study demonstrated in model of colitis-
associated cancer in mice that S1P is produced by upregulation of
SPHK1 in cancer cells14. However, in the obesity state the cell
types that promote the S1P synthesis remain unknown.
Anorexic cancer patients often report early satiety, which
together with a reduced appetite has been postulated to be caused
by the production of factors by the tumour that exerts their effects
by acting on hypothalamic cells, amplifying the anorexigenic
signals45,46. The pro-inflammatory cytokines such as tumour
necrosis factor-a, interleukin 1b and interferon gamma are the
major products secreted by the tumour proposed to play a role in
the aetiology of cancer-induced anorexia45. Studies have reported
that aberrant S1P serum levels were found in animal models of
cancer14,30. Moreover, serum levels of S1P were inversely
correlated with chemotherapy-induced weight gain in women
with breast cancer47. During the tumour development, high levels
of S1P are produced through the upregulation of SPHK1 activity
in cancer cells14. In addition, it has been proposed that serum S1P
elevation represents the communication between cancer cells and
host organism48. In our study, high serum and CSF S1P levels
were found in tumour-bearing rats and it was associated with the
upregulation of S1PR1 protein levels and STAT3 phosphorylation
in the hypothalamus. In addition, intraperitoneal injection of S1P
induced anorexigenic and thermogenic effects. Interestingly, the
disruption of S1P/S1PR1 signalling in the hypothalamus reversed
the anorexia in tumour-bearing animals and prolonged the
survival in these animals. We suggested that in the late-stage of
cancer, S1P produced by cancer or stromal cells acts in the
hypothalamus, contributing to cancer-induced anorexia.
Taken together, our study shows that neuronal S1P/S1PR1 axis
affects the energy homeostasis through the Jak/STAT signalling
and melanocortin system in rodents. We determine that S1PR1
and STAT3 play reciprocal effects in the hypothalamus. We also
report that neuronal S1P/S1PR1/STAT3 signalling plays an
important role in distinct conditions of abnormal feeding
behaviour, such as obesity or cancer-induced anorexia. Thus,
S1P/S1PR1 axis plays a critical role in the energy balance and
represents a potential target for the treatment of obesity and
cancer-induced anorexia as well.
Methods
Animals. Wistar rats, Swiss, C57BL/6J, ob/ob and db/db mice were obtained from
the University of Campinas Breeding Center. The investigation was approved by
the ethics committee of the University of Campinas (CEUA) and followed the
university guidelines for the use of animals in experimental studies and experi-
ments conform to the Guide for the Care and Use of Laboratory Animals, pub-
lished by the U.S. National Institutes of Health (NIH publication number 85-23
revised 1996). Male, 5-week-old Wistar rats and 10-week-old Swiss mice were
obtained from the University of Campinas Breeding Center. The animals were
maintained in 12 h:12 h artificial light–dark cycles, with lights on at 0600 h, and
were housed in individual cages. The animals were randomly divided into two
groups: control, fed on standard rodent chow (3.948 kcal h kg 1) or HFD
(5.358 kcal kg 1) ad libitum for 3 months.
Male (10-week-old) ob/ob and db/db mice and their respective control C57BL/6J
background mice were obtained from The Jackson Laboratory (Bar Harbor, ME).
The mice were bred under specific pathogen-free conditions at the Central Breeding
Center of the University of Campinas and were fed on standard rodent chow. The
number of animals used in each experiment is specified in the legend figure.
Antibodies and chemicals. Anti-EDG-1 (rabbit polyclonal, SC-25489),
Anti-Jak2 (rabbit polyclonal, SC-278), anti-STAT3 (rabbit polyclonal, SC-483),
anti-phospho-IRS-1 (rabbit polyclonal, SC-17199), anti-NPY (goat polyclonal,
SC-14728) and anti-POMC (rabbit polyclonal, SC-20148) antibodies were from
Santa Cruz Biotechnology, Inc. Anti-phospho-Akt (rabbit polyclonal, 9271s), anti-
a tubulin (rabbit polyclonal, 2144), anti-phospho-STAT3 (rabbit polyclonal, 9131)
and anti-phospho-Jak2 (rabbit polyclonal, 3771) was from Cell Signalling
Technology (Beverly, MA, USA). The antibody solution was 1:1,000 for the western
blottings and 1:200 for the immunohistochemistry experiments.
Leptin was from Calbiochem (San Diego, CA, USA). Protein A-Sepharose 6MB
and nitrocellulose paper (Hybond ECL, 0.45mm) were from Amersham Pharmacia
Biotech United Kingdom Ltd (Buckinghamshire, UK). S1P was from Avanti Polar
Lipids Inc. (Alabama, EUA). SEW2871 was from Cayman Chemical (Michigan,
USA), FTY720 was from Cayman Chemical Company (Michigan, USA) and
Cucurbitacin JSI 124 was from Sigma Chemical Co. (St Louis, MO). SHU9119 was
from Tocris Bioscience (Bristol, UK). Routine reagents were purchased from Sigma
Chemical Co. (St Louis, MO) unless otherwise specified.
Determination of S1P levels. After 6 h of fasting, blood was collected from the
cava vein. Plasma was separated by centrifugation (1,100g) for 15min at 4 C and
stored at  80 C until the assay. CSF was obtained from male rats through the
cisterna magna puncture using the stereotaxic apparatus. For serum and CSF S1P
determination, we employed a commercially available Sphingosine-1 phosphate
Assay kit (Echelon Biosciences Inc.).
Cell culture. The mouse hypothalamic tumour cell line GT1-7 were obtained from
the laboratory of Dr Pamela Mellon, San Diego, CA, USA49. GT1-7 cells were
cultured in DMEM medium containing 10% of fetal bovine serum (FBS), with the
addition of antibiotics and fungicides in a humid atmosphere with 37 C, 5% CO2.
The LLC cells were obtained from ATCC, Philadelphia, PA, USA, and the
Walker-256 tumour cell line (originally obtained from the Christ Hospital Line,
National Cancer Institute Bank, Cambridge, UK). Cells were cultured in RPMI
containing 10% FBS and glutamine without addition of antibiotics or fungicides;
they were maintained at 37 C, 5% CO2.
In vitro and in vivo siRNAs transfection. For in vitro study, a total of 5 105 cells
were seeded in a tissue culture plate in complete growth medium and incubated
overnight. Transfection with siRNA targeted to STAT3 (si-STAT3 Silencer Select
Pre-designed s744) or scrambled control siRNA (Silencer Select Pre-designed
4309843) was performed. GT1-7 cells were washed twice with serum- and
glucose-free medium (Opti-MEM, Life Technologies, Gaithersburg, MD, USA) and
then incubated with 2ml of the same medium containing the siRNA (final
concentration of 100 nM) previously mixed with 5 ml of Lipofectamine 2000
(Life Technologies). After 7 h, 1ml of Opti-MEM medium containing 30% FBS was
added to the culture containing siRNAs and Lipofectamine. After 17 h, cells were
cultured in DMEM medium with 10% of FBS for 12 h. After this period, cells were
starved overnight and treated with leptin (40 mmol l 1) for 12 h. Subsequently, the
cells were used for western blot analysis.
For the in vivo study, we used jetSI 10mM S1PR1 siRNA specifc for rodent brain.
The Invivofectamine 2.0 Reagent (Invitrogen, CA, USA) was mixed with the siRNA
targeted to S1PR1 (Silencer Select Pre-designed s65290) or the negative control
(Silencer Select Negative Control si RNA, in vivo ready), according to the
manufacturer’s instructions. The siRNA plus invivofectamine solution (4ml,
1mgml 1) was carefully injected and the experiments were carried out within 72h.
Tumour xenograft models. Male C57BL6/J mice were implanted with 1.0 106
LLC into the dorsal subcutis of the right flank. Four days after the onset of
anorexia, mice were killed, the hypothalamic tissue was excised and mice were
weighed with and without tumour.
Walker-256 tumour cells were obtained from the ascitic fluid of the peritoneal
cavity of Wistar rats 5 days after the intraperitoneal injection of 20 106
carcinoma cells. After cell harvesting, the percentage of viable cells was determined
by using 1% Trypan blue solution in a Neubauer chamber. Tumour cells (2 106
cells in 1ml saline solution) were injected in the right flank after the surgical
implantation of the ICV cannula.
Definition of cancer anorexia. Each animal’s individual baseline 24-h food intake
was defined as the average daily food intake over a period of 3 consecutive days.
Subsequent food intake data are expressed as individual percentages and baseline
daily food intake. In tumour-bearing animals, cancer anorexia was defined as a
single value of o70% of baseline occurring after a steady decline of at least 3 days
duration.
Intracerebroventricular cannulation. After intraperitoneal injection of a mixture
of ketamin (10mg) and diazepam (0.07mg; 0.2ml per 100 g body weight), male
Wistar rats (12-week-old) were stereotaxically instrumented with a chronic
26-gauge stainless steel indwelling guide cannula aseptically placed into the third
ventricle at the midline coordinates of 0.5mm posterior to the bregma and 8.5mm
below the surface of the skull of the rats using the Stoelting stereotaxic apparatus.
The VMH of rats was accessed bilaterally using a 25-gauge needle connected to
Hamilton 25 ml syringes.
VMH and MBH S1P injections. The vehicle and S1P injections in rats were
directed to stereotaxic coordinates 2.3/3.3mm posterior to the bregma, ±0.6mm
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lateral to midline and 10.2mm below the surface of the skull18. In mice, the MBH
injections were made using the coordinates, as previously published by Zhang
et al.44
Intracerebroventricular injections. Rats were deprived of food for 2 h with free
access to water and received 2 ml of bolus injections into the third ventricle, as
follows:
Leptin injection. Rats received ICV infusion of vehicle (saline) or leptin (10 6M)
at 1800 h to evaluate the food consumption. Food intake was determined by
measuring the difference between the weight of chow given and the weight of chow
at the end of a 4- and 12-h period. To evaluate the effects of leptin on Jak/STAT
signalling, the hypothalamic tissue was removed 30min later. To evaluate the
effects of leptin on S1PR1 protein levels, the hypothalamic tissue was removed 8
and 12 h after leptin ICV injection.
Sphingosine-1 phosphate. For western blot analysis, ICV S1P (2 and 50 ng) was
injected into the third ventricle. To evaluate the effects of S1P on Jak/STAT
signalling, the hypothalamic tissue was removed 30min later. To evaluate the
effects of S1P on food intake in rats, ICV injection of S1P (50 ng) was performed at
1800 h.
SEW2871. For western blot analysis, ICV SEW2871 (50 nM) was injected into the
third ventricle. To evaluate the effects of SEW2871 on STAT3 phosphorylation, the
hypothalamic tissue was removed 30min later. To evaluate the effects of SEW2871
on food intake in rats, ICV injection of S1P (50 ng) was performed at 1800 h.
JSI124. For western blot analysis, ICV JSI124 (50 mM) was injected into the third
ventricle. To evaluate the effects of JSI124 on STAT3 phosphorylation, the
hypothalamic tissue was removed 60min later. To evaluate the effects of JSI124 on
food intake in rats, ICV JSI124 injection was performed 30min before the S1P
injection.
FTY720. To evaluate the effects of FTY720 on food intake in tumour-bearing rats,
daily ICV injections (50 mM) was performed at 1800 h. Thirty minutes after the last
injection, the hypothalamic tissue was removed for western blotting analysis.
SHU9119. To evaluate the effects of S1P on melanocortin system, ICV of SHU9119
(1mmol) was performed 30min before the S1P injection. Thereafter, the food
consumption was monitored 4 and 12 h later.
Cerebrospinal fluid injection. CSF from control or from tumour-bearing Wistar rats
were obtained through the introduction of a needle into the cisterna magna
through the skin and/or dura mater using a stereotactic micromanipulator.
Immediately after the liquor sampling, 2 ml were injected into the third ventricle of
control rats to evaluate the food intake. One group of rats received ICV injection of
FTY720 (50 mM) 120min before the CSF injection. CSF injections were performed
at 1800 h.
Mini pump. For chronic S1P ICV administration, obese rats were submitted to
ICV cannulae, which were implanted under ketamin and diazepam as described
above. A catheter tube was connected from the brain infusion cannulae to a mini-
osmotic pump (model 2002, Alzet, DURECT Corporation, Cupertino, CA)
infusing 2.08 ng h 1 of S1P (50 ng within 24 h) or vehicle 0.25 ml h 1. A sub-
cutaneous incision on the dorsal surface of the animal was created where the pump
was inserted.
Intraperitoneal S1P injection. Single intraperitoneal S1P (100 ng) or vehicle
injection was performed in C57BL6/J lean mice. These injections were performed
at 1800 h, and then food consumption and oxygen consumption/carbon dioxide
production were measured in LE405 Gas Analyzer (Panlab—Harvard Apparatus,
Holliston, MA, USA).
Core temperature measurement. An incision was performed in lateral abdom-
inal wall of animals to insert in the peritoneal cavity the temperature datalogger
probe (Subcue Dataloggers, Calgary, AB, Canada). After the surgical wound was
sutured in layers, the animals were recovered from surgery at least 5 days before
experimental protocol. The probe was programmed to acquire data every 15min.
Oxygen consumption and locomotor activity determination. Oxygen con-
sumption and carbon dioxide production were measured in fed animals through
a computer-controlled, open circuit calorimeter system LE405 Gas Analyzer
(Panlab—Harvard Apparatus). Animals were singly housed in clear respiratory
chambers and room air was passed through chambers at a flow rate of ten times the
respective weight of each animal. The air flow within each chamber was monitored
by a sensor Air Supply & Switching (Panlab—Harvard Apparatus). Gas sensors
were calibrated before the onset of experiments with primary gas standards con-
taining known concentrations of O2, CO2 and N2 (Air Liquid, Sao Paulo, Brazil).
The analyses were performed in triplicates of 6min for each chamber.
Therefore, each animal was evaluated for 24 h. Outdoor air reference values
were sampled after every four measurements. Sample air was sequentially passed
through O2 and CO2 sensors to determine O2 and CO2 content, from which
measures of oxygen consumption (VO2) and carbon dioxide production (VCO2)
were estimated. The VO2 and VCO2 were calculated by Metabolism 2.2v software
and expressed in ml g 1min 1, based on Withers equation. The spontaneous
locomotor activity was evaluated over a 24-h period using a computer-controlled
detection system from Panlab—Harvard Apparatus.
Taste reactivity test. The video cameras were placed outside the chamber,
300mm from the ring holding the food cup. After S1P ICV injection, the animal
behaviours were monitored during 15min. The video signal was recorded at 50
frames per second. The videos were analysed by slow-motion playback to count
taste reactivity components. Taste reactivity components were classified as hedonic,
aversive, or neutral, as previously determined.
Immunohistochemistry. Paraformaldehyde-fixed hypothalami were sectioned
(5mm). The sections were obtained from the hypothalami of five rats per group in the
same localization (antero–posterior¼  1.78 from bregma) and were subjected to
regular single- or double-immunofluorescence staining using 4’,6-diamidino-2-phe-
nylindole, anti-S1PR1, anti-POMC, anti-NPY, anti-STAT3 and anti-glial fibrillary
acidic protein antibodies. Analysis and photodocumentation of results were performed
using a LSM 510 laser confocal microscope (Zeiss, Jena, Germany). The anatomical
correlations were made according to the landmarks given in a stereotaxic atlas.
Dissection of the hypothalamic regions. Hypothalamic nuclei of rats were
quickly dissected in a stainless steel matrix with razor blades and frozen in liquid
nitrogen. Later on, each region of the hypothalamus was dissected from 1-mm-
thick sagittal sections of fresh brain. PVN, Arc and VMH plus DMH were dissected
from the first sections from the midline of the brain. Coordinates for each hypo-
thalamic region are as follows; PVN: square area with anterior margin (posterior
region of anterior commisure), dorsal margin (border with thalamus), ventral
margin and posterior margin (white matter separating PVN/anterior hypothalamus
and VMH/DMH); VMH plus DMH: triangular area with anterior margin (white
matter separating PVN/anterior hypothalamus and VMH/DMH), posterior margin
(border with mammilary body) and ventral margin (border with Arc); Arc: ventral
part of the medial hypothalamus with anterior and dorsal margin and posterior
margin (border with mammilary body).
mRNA isolation and real-time PCR. Hypothalamic total RNA was extracted
using Trizol reagent (Life Technologies), according to the manufacturer’s
recommendations. Total RNA was rendered genomic DNA free by digestion with
Rnase-free Dnase (RQ1, Promega, Madison, WI, USA). Rats were deprived of food
for 9 h for real-time PCR analysis. Real-time PCR and mRNA isolation were
performed using a commercial kit, as follows: POMC: Rn00595020_m1, NPY:
Rn00561681_m1, GAPD, 4352338E, S1PR1: Rn.PT.56a.12493708 for rat and
RPS-29 (NCBI: NM012876), sense: 59-AGGCAAGATGGGTCACCAGC-39,
antisense: 59-AGTCGAATCATCCATTCAGGTCfG-39.
Subcellular fractionation. The hypothalamus from rats were homogenized in 2
volumes of STE buffer (0.32M sucrose, 20mM Tris HCl (pH 7.4), 2mM EDTA,
1mM dithiothreitol, 100mM sodium fluoride, 100mM sodium pyrophosphate,
10mM sodium orthovanadate, 1mM phenylmethylsulphonyl fluoride (PMSF) and
0.1mg aprotinin per ml) at 4 C. The homogenates were centrifuged (1,000g,
25min, 4 C) to obtain pellets. The pellets were washed once with STE buffer
(1.000 g, 10min, 4 C) and suspended in Triton buffer (1% Triton X-100, 20mM
Tris HCl (pH 7.4), 150mM NaCl, 200mM EDTA, 10mM sodium orthovanadate,
1mM PMSF, 100mM NaF, 100mM sodium pyrophosphate and 0.1mg aprotinin
per ml), kept on ice for 30min and centrifuged (15,000g, 30min, 4 C) to obtain the
nuclear fraction. The supernatant was centrifuged (100,000g, 60min, 4 C) to
obtain the cytosol fraction and the pellet, which was suspended in STE bufferþ 1%
NP-40, kept on ice for 20min and centrifuged (100,000g, 20min) to obtain the
membrane fraction. The fractions were treated with Laemmli buffer with 100mM
dithiothreitol and heated in a boiling water bath for 5min, and aliquots (0.2mg of
protein) were subjected to western blotting analysis.
Western blotting analysis and immunoprecipitation. The animals were anaes-
thetized, and the hypothalamus, cerebellum, midbrain, cortex, liver, heart, gas-
trocnemius muscle and adipose tissue were quickly removed, minced coarsely and
homogenized immediately in a freshly prepared ice-cold buffer (1% Triton X-100,
100mmol l 1 Tris pH 7.4, 100mmol l 1 sodium pyrophosphate, 100mmol l 1
sodium fluoride, 10mmol l 1 EDTA, 10mmol l 1 sodium vanadate, 2mmol l 1
phenylPMSF and 0.1mg aprotinin) suitable for preserving the phosphorylation
states of enzymes.
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Jak2 was immunoprecipitated from rat hypothalami. Antibodies used for
immunoblotting were anti-S1PR1 and anti-Jak2. Blots were exposed to preflashed
Kodak XAR film. Band intensities were quantified by optical densitometry
(UN-SCAN-IT gel, 6.1) of the developed autoradiographs. Uncropped images of
Western blots are shown in Supplementary Fig. 4.
Bioinformatics analysis. Correlation analyses were performed using hypotha-
lamic mRNAs of BXD inbred family (Hypothalamus Affy MoGene 1.0 ST
(Nov10)) and are accessible on Genetwork (http://www.genenetwork.org) and
NCBI GEO (GSE36674, http://www.ncbi.nlm.nih.gov/geo) as described in (PMID:
22939713). Correlation matrix graph was built using corrgram package in R (http://
www.r-project.org). The values used are available in the Supplementary Tables 1
and 2.
Statistical analysis. All numeric results are expressed as the means±s.e.m. of the
indicated number of experiments. The results of blots are presented as direct
comparisons of bands in autoradiographs and quantified by optical densitometry
(UN-SCAN-IT gel, 6.1). Statistical analysis was performed using the Student’s t-test
and analysis of variance test with the Bonferroni post test. Significance was
established at the Po0.05 level. The survival curves were estimated using Kaplan–
Meier’s estimates, and curves were compared using the log-rank test and the level
of significance was set at Po0.001.
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